27.09.2021 • News

Huntsman Expands Specialty Amines

Huntsman has completed the initial phases of a project at Conroe, Texas, USA, to expand and widen its portfolio of E-Grade specialty amines, including quaternary amine alternatives to tetramethylammonium hydroxide and related products.

The new facility, which will include purification, blending and cleanroom packaging, is expected to be operational in 2023. E-Grade specialty amines are used by the electronics industry to enhance the performance of semiconductor manufacturing.

“This expansion would leverage our expertise as one of the world’s leading semiconductor-grade amine suppliers to improve customer experience, meet stringent quality expectations, and offer a greater range of products to the growing and dynamic semiconductor industry. This project also would satisfy many of our customers’ requests to have a North American supply source for these vitally needed products,” said Chuck Hirsch, senior vice president of Huntsman Performance Products.

The project comes less than a month after Huntsman announced an expansion of its specialty amines and polyurethane catalysts at Petfurdo, Hungary, in order to meet growing demand. The multi-million-dollar project is expected to be completed by mid-2023.

Author: Elaine Burridge, Freelance Journalist

Huntsman has completed the initial phases of a project at Conroe, Texas, USA,...
Huntsman has completed the initial phases of a project at Conroe, Texas, USA, to expand and widen its portfolio of E-Grade specialty amines, including quaternary amine alternatives to tetramethylammonium hydroxide and related products. The new facility is due online in 2023. (c) Huntsman

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.